2Rajkumar SV,Kyle RA,Therneau TM,et al.Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance[J].Blood,2005,106:812 -817.
3Lecouver FE,Malghem J,Michaux JL,et al.Vertebral compression fractures in multiple myeloma.Part Ⅱ.Assessment of fracture risk with MR imaging of spinal bone marrow[J].Radiology,1997,204:201-205.
4Durie BG,Salmon SE.A clinical staging system for multiple myeloma.Correlation of measured myeloma cell mass with presenting clinical features,response to treatment,and survival[J].Cancer,1975,36:842-854.
5Greipp PR,San Miguel J,Durie BG,et al.International staging system for multiple myeloma[J].J Clin Oncol,2005,23:3412 -3420.
6Fonseca R,Blood E,Rue M,et al.Clinical and biologic implications of recurrent genomic aberrations in myeloma[J].Blood,2003,101:4569-4575.
7Rajkumar SV,Blood E,Vesole D,et al.Phase Ⅲ clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma:a clinical trial coordinated by the Eastern Cooperative Oncology Group[J].J Clin Oncol,2006,24:431 -436.
8Harousseau JL,Attal M,Leleu X,et al.Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma:results of an IFM phase Ⅱ study[J].Haematologica,2006,91:1498-1505.
9Harousseau JL,Marit G,Caillot D,et al.Velcade/deamethasone (Vel/Dex) versus VAD as induction treatment prior to autologous stem cell transplantation (ASCT)in newly diagnosed multiple myeloma(MM):an interim analysis of the IFM 2005 -01 randomized multicenter phase Ⅲ trial[J].Blood,2006,108:56.
10Rajkumar SV,Hayman SR,Lacy MQ,et al.Combination therapy with lenalidomide plus dexamethasone(Rev/Dex) for newly diagnosed myeloma[J].Blood,2005,106:4050-4053.
7Task force for diagnosis and treatment of acute and chronic heart failure 2008 of European society of cardiology, Dickstein K, Cohen- Solal A, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the Euro- pean society of cardiology. Developed in collaboration with the heart failure association of the ESC ( HFA ) and endorsed by the European society of intensive care medicine ( ESICM ) [ J ]. Eur Heart J.2008.29(19) ;2388 -2442.
8Conte LG,Figueroa MG,Lois VV,et al. Clinical features and survival of Chilean patients with multiple myeloma [ J ]. Rev Med Chil,2007,135(9) :1111 - 1117.
9Kariyawasan CC, Hughes DA ,Jayatillake MM, et al. Multiple myeloma:canses and consequences of delay in diagnosis [ J ]. QJM, 2007,100(10) :635 -640.
10Sedaghat D,Zakir RM,Choe J,et al. Cardiac amyloidosis in a patient with multiple myeloma:a case report and review of literature [ J ]. J Clin Ultrasound,2009,37 ( 3 ) : 179 - 184.
